Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 4
1992 10
1993 14
1994 26
1995 29
1996 39
1997 32
1998 29
1999 33
2000 39
2001 31
2002 29
2003 31
2004 34
2005 28
2006 22
2007 12
2008 17
2009 34
2010 26
2011 33
2012 31
2013 20
2014 15
2015 26
2016 28
2017 18
2018 14
2019 27
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

711 results
Results by year
Filters applied: . Clear all
Page 1
The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies.
Chatterjee K, Das P, Chattopadhyay NR, Mal S, Choudhuri T. Chatterjee K, et al. Heliyon. 2019 Nov 14;5(11):e02624. doi: 10.1016/j.heliyon.2019.e02624. eCollection 2019 Nov. Heliyon. 2019. PMID: 31840114 Free PMC article. Review.
Changes in the expression patterns of these isoforms are noted in many human cancers. Proteins of certain human herpesviruses, like Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), interact with p53 family members and …
Changes in the expression patterns of these isoforms are noted in many human cancers. Proteins of certain human herpesviruses, …
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L, Kelly GL. Fitzsimmons L, et al. Viruses. 2017 Nov 13;9(11):339. doi: 10.3390/v9110339. Viruses. 2017. PMID: 29137176 Free PMC article. Review.
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are as yet, no EBV-targeted therapies available. ...Since manipulation of the cell …
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributo …
Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W, Liu MG, Zhang JB, Zhang JJ, Sun MM, Yu QK. Song W, et al. Eur Rev Med Pharmacol Sci. 2016;20(6):1093-7. Eur Rev Med Pharmacol Sci. 2016. PMID: 27049262 Free article.
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. RESULTS: In the observation group, the expression rates of EBV(+), p53(+), Bcl-2(+), Rb(-), and c-Myc(+) were significantly higher than those, …
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. RESULTS: In the …
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM. Tornesello ML, et al. Cancers (Basel). 2018 Jun 22;10(7):213. doi: 10.3390/cancers10070213. Cancers (Basel). 2018. PMID: 29932446 Free PMC article. Review.
The Epstein⁻Barr virus (EBV) BZLF1, the high-risk human papillomavirus (HPV) E6, and the hepatitis C virus (HCV) NS5 proteins have shown to directly bind to and degrade p53. The hepatitis B virus (HBV) HBx and the human T cell lymphotropic virus-1 (HTL …
The Epstein⁻Barr virus (EBV) BZLF1, the high-risk human papillomavirus (HPV) E6, and the hepatitis C virus (HCV) NS5 proteins …
Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A, Khemaleelakul U, Pongsiriwet S, Pintong J. Iamaroon A, et al. J Oral Pathol Med. 2004 Jan;33(1):30-6. doi: 10.1111/j.1600-0714.2004.00192.x. J Oral Pathol Med. 2004. PMID: 14675138
BACKGROUND: The objectives of the study were to determine the association between Epstein-Barr virus (EBV) and oral squamous cell carcinoma (OSCC), to compare the expression of p53 and Ki67 between normal oral mucosa, oral hyperkeratosis, oral pre-malignant dysplasi …
BACKGROUND: The objectives of the study were to determine the association between Epstein-Barr virus (EBV) and oral squamous cell car …
Oral non-Hodgkin lymphomas: studies of EBV and p53 expression.
Iamaroon A, Pongsiriwet S, Mahanupab P, Kitikamthon R, Pintong J. Iamaroon A, et al. Oral Dis. 2003 Jan;9(1):14-8. doi: 10.1034/j.1601-0825.2003.01808.x. Oral Dis. 2003. PMID: 12617252
Human immuno-deficiency virus (HIV) status was documented in five of the 11 patients and three were known to be HIV-positive. ...Eight of 11 cases (72.7%) showed positive expression of p53 protein. Four of 10 cases (40%) expressed EBV-encoded RNA (EBER) trans
Human immuno-deficiency virus (HIV) status was documented in five of the 11 patients and three were known to be HIV-positive. ...Eigh
Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu Y, Lu Y, Qin Z, Zhang X, Lu J, Ou C, Li Z, Zhang X, Liu P, Xiong W, Li G, Yan Q, Ma J. Zheng X, et al. J Virol. 2018 Nov 12;92(23):e01022-18. doi: 10.1128/JVI.01022-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30209170 Free PMC article.
Epstein-Barr virus (EBV) is the first human virus found to encode many microRNAs. It is etiologically linked to nasopharyngeal carcinoma and EBV-associated gastric carcinoma. ...Unlike in most human solid tumors, TP53 mutations are rare in nasopharynge …
Epstein-Barr virus (EBV) is the first human virus found to encode many microRNAs. It is etiologically linked to nasopharyngeal …
Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan D, Michel A, Waterboer T, Song M, Gulley ML, Dominguez RL, Yatabe Y, Kim S, Cortes-Martinez G, Lissowska J, Zabaleta J, Pawlita M, Rabkin CS. Camargo MC, et al. Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):414-419. doi: 10.1158/1055-9965.EPI-19-0790. Epub 2019 Nov 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31719065
T1) for patients with EBV-positive versus EBV-negative tumors were significantly elevated for higher antibodies against EBNA (2.6 for T2 and 13 for T3), VCA (1.8 for T2 and 2.4 for T3), EA-D (6.0 for T2 and 44 for T3), and ZEBRA (4.6 for T2 and 12 for …
T1) for patients with EBV-positive versus EBV-negative tumors were significantly elevated for higher antibodies against EBNA ( …
Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α.
Park GB, Park SH, Kim D, Kim YS, Yoon SH, Hur DY. Park GB, et al. Int J Oncol. 2016 Jul;49(1):411-21. doi: 10.3892/ijo.2016.3502. Epub 2016 Apr 26. Int J Oncol. 2016. PMID: 27121748
ROS and wild-type p53 play a critical role in berberine-induced cytotoxic effects. In this study, we investigated the correlation between XAF1 and functional p53 in EBV-transformed B cells or cancerous B cells after treatment with berberine. ...Taken together …
ROS and wild-type p53 play a critical role in berberine-induced cytotoxic effects. In this study, we investigated the correlation bet …
P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
Takahara M, Kishibe K, Bandoh N, Nonaka S, Harabuchi Y. Takahara M, et al. Hum Pathol. 2004 Jan;35(1):86-95. doi: 10.1016/j.humpath.2003.08.025. Hum Pathol. 2004. PMID: 14745729
The aim of this study is to determine the p53, N- and K-ras, and beta-catenin status in this lymphoma in relation to EBV status and clinical features. ...LMP-1 was expressed in 15 (48%) tumors, and p53 and beta-catenin protein were overexpressed in 18 (56%) a …
The aim of this study is to determine the p53, N- and K-ras, and beta-catenin status in this lymphoma in relation to EBV statu …
711 results
Jump to page
Feedback